The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
The global Heparin market was valued at US$ 2337 million in 2023 and is anticipated to reach US$ 3067.9 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
Report Scope
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (B Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Shenzhen Hepalink Pharmaceutical
- Yantai Dongcheng Pharmaceutical
- Pfizer
- Bioibérica
- Changzhou Qianhong Biopharma
- Nanjing King-friend Biochemical Pharmaceutical
- Hebei Changshan Biochemical Pharmaceutical
- Qingdao Jiulong Biopharmaceutical
- Opocrin
- Dongying Tiandong Pharmaceutical
- Aspen Oss
- Yino Pharma
- Nanjing Xinbai Pharmaceutical
- Hubei Enoray Biopharmaceutical
- Cisen Pharmaceutical
Segment by Type
- Heparin Sodium
- Heparin Calcium
Segment by Application
- UFH
- LMWH
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Heparin Market Overview
1.1 Product Overview and Scope of Heparin
1.2 Heparin Segment by Type
1.2.1 Global Heparin Market Value Comparison by Type (2024-2030)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin Segment by Application
1.3.1 Global Heparin Market Value by Application: (2024-2030)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Market Size Estimates and Forecasts
1.4.1 Global Heparin Revenue 2019-2030
1.4.2 Global Heparin Sales 2019-2030
1.4.3 Global Heparin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heparin Market Competition by Manufacturers
2.1 Global Heparin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heparin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heparin Average Price by Manufacturers (2019-2024)
2.4 Global Heparin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin, Product Type & Application
2.7 Heparin Market Competitive Situation and Trends
2.7.1 Heparin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heparin Players Market Share by Revenue
2.7.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin Retrospective Market Scenario by Region
3.1 Global Heparin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heparin Global Heparin Sales by Region: 2019-2030
3.2.1 Global Heparin Sales by Region: 2019-2024
3.2.2 Global Heparin Sales by Region: 2025-2030
3.3 Global Heparin Global Heparin Revenue by Region: 2019-2030
3.3.1 Global Heparin Revenue by Region: 2019-2024
3.3.2 Global Heparin Revenue by Region: 2025-2030
3.4 North America Heparin Market Facts & Figures by Country
3.4.1 North America Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heparin Sales by Country (2019-2030)
3.4.3 North America Heparin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heparin Market Facts & Figures by Country
3.5.1 Europe Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heparin Sales by Country (2019-2030)
3.5.3 Europe Heparin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Market Facts & Figures by Country
3.6.1 Asia Pacific Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heparin Sales by Country (2019-2030)
3.6.3 Asia Pacific Heparin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Market Facts & Figures by Country
3.7.1 Latin America Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heparin Sales by Country (2019-2030)
3.7.3 Latin America Heparin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heparin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heparin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sales by Type (2019-2030)
4.1.1 Global Heparin Sales by Type (2019-2024)
4.1.2 Global Heparin Sales by Type (2025-2030)
4.1.3 Global Heparin Sales Market Share by Type (2019-2030)
4.2 Global Heparin Revenue by Type (2019-2030)
4.2.1 Global Heparin Revenue by Type (2019-2024)
4.2.2 Global Heparin Revenue by Type (2025-2030)
4.2.3 Global Heparin Revenue Market Share by Type (2019-2030)
4.3 Global Heparin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heparin Sales by Application (2019-2030)
5.1.1 Global Heparin Sales by Application (2019-2024)
5.1.2 Global Heparin Sales by Application (2025-2030)
5.1.3 Global Heparin Sales Market Share by Application (2019-2030)
5.2 Global Heparin Revenue by Application (2019-2030)
5.2.1 Global Heparin Revenue by Application (2019-2024)
5.2.2 Global Heparin Revenue by Application (2025-2030)
5.2.3 Global Heparin Revenue Market Share by Application (2019-2030)
5.3 Global Heparin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shenzhen Hepalink Pharmaceutical Heparin Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yantai Dongcheng Pharmaceutical Heparin Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Heparin Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bioibérica
6.4.1 Bioibérica Corporation Information
6.4.2 Bioibérica Description and Business Overview
6.4.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bioibérica Heparin Product Portfolio
6.4.5 Bioibérica Recent Developments/Updates
6.5 Changzhou Qianhong Biopharma
6.5.1 Changzhou Qianhong Biopharma Corporation Information
6.5.2 Changzhou Qianhong Biopharma Description and Business Overview
6.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changzhou Qianhong Biopharma Heparin Product Portfolio
6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.6 Nanjing King-friend Biochemical Pharmaceutical
6.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
6.6.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Portfolio
6.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.6.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
6.6.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.6.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hebei Changshan Biochemical Pharmaceutical Heparin Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Qingdao Jiulong Biopharmaceutical Heparin Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Corporation Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Opocrin Heparin Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Corporation Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dongying Tiandong Pharmaceutical Heparin Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Corporation Information
6.11.2 Aspen Oss Heparin Description and Business Overview
6.11.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Aspen Oss Heparin Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Corporation Information
6.12.2 Yino Pharma Heparin Description and Business Overview
6.12.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yino Pharma Heparin Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Nanjing Xinbai Pharmaceutical
6.13.1 Nanjing Xinbai Pharmaceutical Corporation Information
6.13.2 Nanjing Xinbai Pharmaceutical Heparin Description and Business Overview
6.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nanjing Xinbai Pharmaceutical Heparin Product Portfolio
6.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.14 Hubei Enoray Biopharmaceutical
6.14.1 Hubei Enoray Biopharmaceutical Corporation Information
6.14.2 Hubei Enoray Biopharmaceutical Heparin Description and Business Overview
6.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hubei Enoray Biopharmaceutical Heparin Product Portfolio
6.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical Heparin Description and Business Overview
6.15.3 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cisen Pharmaceutical Heparin Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Industry Chain Analysis
7.2 Heparin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Production Mode & Process
7.4 Heparin Sales and Marketing
7.4.1 Heparin Sales Channels
7.4.2 Heparin Distributors
7.5 Heparin Customers
8 Heparin Market Dynamics
8.1 Heparin Industry Trends
8.2 Heparin Market Drivers
8.3 Heparin Market Challenges
8.4 Heparin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
